Facebook
X
LinkedIn
ForwardHerbert Wertheim Cancer Institute and AAOM Oral Oncology Symposium
This symposium will explore the evolving impact of modern cancer therapies on oral health, with a focus on oral mucositis, osteonecrosis of the jaw, and oral potentially malignant disorders. Participants will gain practical insights into the recognition, prevention, surveillance, and management of these complex conditions, including emerging therapies and clinical advances. The program will also address the long-term oral health challenges faced by cancer survivors and the importance of multidisciplinary care in optimizing functional outcomes, quality of life, and survivorship.
Learning Objectives
Upon completion of this symposium, participants should be better able to:
- Apply MASCC/ISOO guideline-based strategies for prevention and management of oral complications in head and neck cancer.
- Identify early signs of oral and oropharyngeal cancer to support timely referral and multidisciplinary care.
- Integrate oral health management into cancer treatment and survivorship planning.
- Evaluate emerging evidence and clinical advances in oral toxicity management and supportive oncology care.
- Incorporate innovative therapies and technologies to improve treatment tolerance, function, and quality of life.
- Strengthen interdisciplinary communication and care coordination using evidence-based frameworks.
Who Should Attend
Internists, Family Practitioners, Dentists, Dental Hygienists, Nurses and Nurse Practitioners, Physician Assistants, Dental Students and Trainees
Registration and Fees
| Baptist Health Employees and AAOM Members | Community Healthcare Professionals | |
| Physicians and Dentists | $350 | $450 |
| Nurses and Hygienists | $150 | $275 |
| Fellows, Physicians-in-Training* and Students | $100 | $150 |
| Other Healthcare Professionals | $300 | $350 |
* Registration must be accompanied by a letter from the Fellowship/Residency Director.
Course Summary
Agenda
Friday, April 16, 2027
| 7:30 - 8:30 a.m. | Breakfast, Exhibits and Poster Presentations |
| 8:30 - 8:45 a.m. | Welcome and Introductions |
| Keynote: The Evolution of Cancer Therapy - Are We Improving Without Compromising Oral Health | |
| 8:45 - 9:10 a.m. | Head & Neck Surgery |
| 9:10 - 9:35 a.m. | Radiation Oncology |
| 9:35 - 10:00 a.m. | Oral Medicine/Oncology |
| 10:00 - 10:15 a.m. | Question and Answer Session |
| 10:15 - 10:45 a.m. | Break, Exhibits and Poster Viewing |
| Oral Mucositis Toxicities Across the Cancer Continuum | |
| 10:45 - 11:10 a.m. | Oral Mucositis in Modern Oncology |
| 11:10 - 11:35 a.m. | Photobiomodulation: From Emerging Technologies to Standard of Care? |
| 11:35 a.m. - 12:00 p.m. | Implementing Oral Toxicity Monitoring in Oncology Practice |
| 12:00 - 12:15 p.m. | Question and Answer Session |
| 12:15 - 1:15 p.m. | Lunch and Product Theater |
| Bone Health in Oncology | |
| 1:15 - 1:40 p.m. | MRONJ and ORN: Mechanisms, Risk Factors and Contemporary Management |
| 1:40 - 2:05 p.m. | Beyond Conservative Care: Surgical Decision-Making in Osteonecrosis of the Jaw |
| 2:05 - 2:30 p.m. | Dental Clearance: The First Line of Defense Against Osteonecrosis |
| 2:30 - 2:45 p.m. | Question and Answer Session |
| 2:45 - 3:00 p.m. | Break, Exhibits and Poster Viewing |
| Oral Abstracts Presentation | |
| 3:00 - 3:45 p.m. | Poster Viewing |
| 3:45 - 4:00 p.m. | Closing Remarks and Adjournment |
Saturday, April 17, 2027
| 7:30 - 8:30 a.m. | Breakfast and Exhibits |
| More Than Side Effects, Taste, Salivary Function and Quality of Life in Cancer Survivors | |
| 8:30 - 8:55 a.m. | Taste Dysfunction in Oncology: Mechanisms and Management |
| 8:55 - 9:20 a.m. | Xerostomia and Salivary Gland Dysfunction Across Cancer Therapies |
| 9:20 - 9:45 a.m. | Nutrition and Survivorship: Measuring What Matters to Patients |
| 9:45 - 10:00 a.m. | Question and Answer Session |
| 10:00 - 10:15 a.m. | Break and Exhibits |
| Beyond Surveillance: Oral Potentially Malignant Disorders and Advances in Leukoplakia Care | |
| 10:15 - 10:45 a.m. | Oral Potentially Malignant Disorders (OPMD): Recognizing and Risk-Stratifying Oral Leukoplakia |
| 10:45 - 11:15 a.m. | Beyond Surgery: Emerging Therapies and Clinical Trials for Oral Leukoplakia |
| 11:15 a.m. - 12:15 p.m. | Lunch and Exhibits |
| The Patient Journey After Cancer: An Expert Panel Discussion | |
| 12:15 - 1:30 p.m. | Panel Discussion |
| 1:30 - 1:45 p.m. | Question and Answer Session |
| 1:45 - 2:00 p.m. | Closing Remarks and Adjournment |
NOTE: Schedule subject to change.
About the Venue
Next to Baptist Hospital, Hilton Miami is two miles from Dadeland Mall and 10 minutes from Dadeland South Metro Station. Miami International Airport is 13 miles away. Hilton Miami offers a wellness center with yoga and Pilates classes plus massages, a heated pool, and guest rooms with fitness equipment. Hilton Miami Dadeland has met cleanliness standards for a WELL Health-Safety Rating.
Symposium Director
Oral Medicine Specialist
Baptist Health Herbert Wertheim Cancer Institute
Miami, Florida